National Technical Advisory Group on Immunisation (NTAGI) will be reviewing the data of COVID19 vaccines for the 5-12 age group on 4th May, as per sources.
This comes as the government panel earlier meeting on the issue remained inconclusive. India's drug regulator, DCGI, had on Tuesday granted emergency use authorisation for Biological E's COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotech's Covaxin for children in the age group of six to 12 years.
And following this, Union Health Minister Mansukh Mandaviya said on Thursday, "The decision (on vaccination for 5-12 age group) will be taken on the basis of the recommendation of an expert committee."